Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.
Journal: Endocrine-related cancer
Published: January 28, 2026
Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas.
Journal: Endocrine-related cancer
Published: January 28, 2026
What is our current understanding of insulin-derived amyloidosis?
Journal: Expert opinion on drug safety
Published: November 12, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Journal: Nature communications
Published: October 22, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
Update in the management of gastroenteropancreatic neuroendocrine tumors.
Journal: Cancer
Published: February 07, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Journal: Cancer research communications
Published: February 07, 2024
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but When.
Journal: Cancers
Published: January 09, 2024
Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors.
Journal: Cancers
Published: May 29, 2023
Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatin.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 04, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026